Form 8-K - Current report:
SEC Accession No. 0000896264-25-000175
Filing Date
2025-07-01
Accepted
2025-07-01 11:54:40
Documents
16
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K usna-20250627.htm   iXBRL 8-K 32503
2 EX-10.1 ex101thirdamendedandrestat.htm EX-10.1 1990698
3 EX-10.2 ex102amendedandrestatedsec.htm EX-10.2 136243
7 image_0.jpg GRAPHIC 790
8 image_1.jpg GRAPHIC 6192
  Complete submission text file 0000896264-25-000175.txt   2557043

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20250627.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20250627_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20250627_pre.xml EX-101.PRE 12504
18 EXTRACTED XBRL INSTANCE DOCUMENT usna-20250627_htm.xml XML 2732
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 251094956
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)